Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Undervalued
Consensus
Playing (BUY)
Best For
Capital Growth

How This Company Makes Money

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Business Quality Score
Dividend Score

Sales Growth CPRX

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin CPRX

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income CPRX

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM CPRX

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio CPRX

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Catalyst Pharmaceuticals Inc CPRX

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself CPRX

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 18.20
Forward PE 12.95
Enterprise Value Revenue 5.20
Price Sales TTM 6.46
Enterprise Value EBITDA 10.14
Price Book MRQ 3.81

Bottom Line

Catalyst Pharmaceuticals Inc

CPRX
Current price
31.49 USD 0 USD (0.00%)
Last closed 31.49 USD
ISIN US14888U1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 854 925 568 USD
Yield for 12 month +60.01 %
1Y
3Y
5Y
10Y
15Y
CPRX
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+588 989 000 USD

Last Year

+491 734 000 USD

Current Quarter

+149 390 000 USD

Last Quarter

+152 613 000 USD

Current Year

+501 736 000 USD

Last Year

+422 889 000 USD

Current Quarter

+125 212 000 USD

Last Quarter

+126 539 000 USD
EBITDA 305 828 992 USD
Operating Margin TTM 49.02 %
Price to Earnings 18.20
Return On Assets TTM 16.27 %
PEG Ratio 0.96
Return On Equity TTM 24.50 %
Wall Street Target Price 31.67 USD
Revenue TTM 596 958 016 USD
Book Value 8.29 USD
Revenue Per Share TTM 4.87 USD
Dividend Share
Quarterly Revenue Growth YOY 5.60 %
Dividend Yield
Gross Profit TTM 501 657 984 USD
Earnings Per Share 1.73 USD
Diluted EPS TTM 1.73 USD
Most Recent Quarter I 2026
Quarterly Earnings Growth YOY 11.10 %
Profit Margin 37.08 %
Price to Free Cash Flow TTM 18.52

Technical Indicators CPRX

For 52 Weeks

19.05 USD 32.56 USD
50 Day MA 31.26 USD
Shares Short Prior Month 7 950 863
200 Day MA 25.41 USD
Short Ratio 4.11
Shares Short 7 845 889
Short Percent 6.78 %